Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001307666 | SCV001497087 | uncertain significance | Nephronophthisis 15 | 2020-07-01 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with CEP164-related conditions. This sequence change replaces arginine with proline at codon 1361 of the CEP164 protein (p.Arg1361Pro). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and proline. This variant is present in population databases (rs148987415, ExAC 0.009%). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |